Alivus Life Sciences allotted 195,833 equity shares under its Employee Stock Option Scheme 2021.
The allotment increases the company's paid-up share capital to Rs 24.59 crore from Rs 24.55 crore.
The board approved the share issuance on October 29, 2026, as disclosed in a regulatory filing.